Trials / Conditions / Extensive Stage Small Cell Lung Carcinoma

Extensive Stage Small Cell Lung Carcinoma

10 registered clinical trials studyying Extensive Stage Small Cell Lung Carcinoma.

Status	Trial	Sponsor	Phase
Withdrawn	ALCMI-005: Pembrolizumab and Epacadostat in Treating Patients With Extensive Stage Small Cell Lung Cancer NCT03402880	City of Hope Medical Center	Phase 2
Terminated	Tumor-Treating Fields Therapy in Preventing Brain Tumors in Participants With Extensive-Stage Small Cell Lung NCT03607682	Vanderbilt-Ingram Cancer Center	N/A
Completed	Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer NCT03154190	Stanford University	N/A
Completed	Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Limited Stage or Extensive Stage Small NCT02635009	NRG Oncology	Phase 2 / Phase 3
Completed	Pembrolizumab and Concurrent Chemoradiotherapy or Radiation Therapy in Treating Patients With Small Cell Lung NCT02402920	M.D. Anderson Cancer Center	Phase 1
Completed	MK-3475 as Maintenance Therapy in Extensive Stage SCLC NCT02359019	Barbara Ann Karmanos Cancer Institute	Phase 2
Completed	Sirolimus and Auranofin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer or Small Ce NCT01737502	Mayo Clinic	Phase 1 / Phase 2
Completed	Cisplatin and Etoposide With or Without Veliparib in Treating Patients With Extensive Stage Small Cell Lung Ca NCT01642251	National Cancer Institute (NCI)	Phase 1 / Phase 2
Completed	A Study of LY2510924 in Participants With Extensive-Stage Small Cell Lung Carcinoma NCT01439568	Eli Lilly and Company	Phase 2
Completed	A Randomized Phase II Study of Cisplatin and Etoposide in Combination With Either Hedgehog Inhibitor GDC-0449 NCT00887159	National Cancer Institute (NCI)	Phase 2